A Long-Term Study of Rovalpituzumab Tesirine
Clinical trial NCT03543358 · COMPLETED
Trial details
- NCT number
- NCT03543358
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2019-11-26
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.